COVID-19 in the Asia Pacific: Impact on climate change, allergic diseases and One Health
- PMID: 37389098
- PMCID: PMC10166246
- DOI: 10.5415/apallergy.0000000000000021
COVID-19 in the Asia Pacific: Impact on climate change, allergic diseases and One Health
Abstract
Climate change and environmental factors such as air pollution and loss of biodiversity are known to have a major impact not only on allergic diseases but also on many noncommunicable diseases. Coronavirus disease 2019 (COVID-19) resulted in many environmental changes during the different phases of the pandemic. The use of face masks, enhanced hand hygiene with hand rubs and sanitizers, use of personal protective equipment (gowns and gloves), and safe-distancing measures, reduced the overall incidence of respiratory infections and other communicable diseases. Lockdowns and border closures resulted in a significant reduction in vehicular traffic and hence environmental air pollution. Paradoxically, the use of personal protective equipment and disposables contributed to an increase in environmental waste disposal and new problems such as occupational dermatoses, especially among healthcare workers. Environmental changes and climate change over time may impact the exposome, genome, and microbiome, with the potential for short- and long-term effects on the incidence and prevalence of the allergic disease. The constant use and access to mobile digital devices and technology disrupt work-life harmony and mental well-being. The complex interactions between the environment, genetics, immune, and neuroendocrine systems may have short- and long-term impact on the risk and development of allergic and immunologic diseases in the future.
Keywords: Climate change; Exposome; Genome; Microbiota; Pollution.
Copyright © 2023. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
References
-
- Pawankar R, Wang JY. Climate change, air pollution, and biodiversity in Asia Pacific and impact on respiratory allergies. Immunol Allergy Clin North Am 2021;41:63–71. - PubMed
-
- Pacheco SE, Guidos-Fogelbach G, Annesi-Maesano I, Pawankar R, D' Amato G, Latour-Staffeld P, Urrutia-Pereira M, Kesic MJ, Hernandez ML.; American Academy of Allergy, Asthma & Immunology Environmental Exposures and Respiratory Health Committee. Climate change and global issues in allergy and immunology. J Allergy Clin Immunol 2021;148:1366–77. - PubMed
-
- Agache I, Akdis C, Akdis M, et al. Lancet 2023. (in press).
-
- Pawankar R, Thong BY, Tiongco-Recto M, Wang J-Y, Abdul Latiff AH, Thien F, Oh J-W, Kamchaisatian W, Rengganis I, Udwadia ZF, Dhar R, Munkhbayarlakh S, Narantsetseg L, Le Pham D, Leung TF, Zhang L; APAAACI COVID-19 Working Group. Asia-Pacific perspectives on the COVID-19 pandemic. Allergy 2021;76:2998–01. - PMC - PubMed
-
- Pawankar R, Thong BY, Tiongco-Recto M, Wang J-Y, Latiff AHA, Leung TF, Li PH, Lobo RCM, Lucas M, Oh J-W, Kamchaisatian W, Nagao M, Rengganis I, Udwadia ZF, Dhar R, Munkhbayarlakh S, Narantsetseg L, Pham DL, Zhang Y, Zhang L. Asia Pacific perspectives on the second year of the COVID-19 pandemic: a follow-up survey. Clin Exp Allergy 2022;52:965–73. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources